Ana Cespedes
Directeur/Membre du Conseil chez ARGENX SE
Fortune : 84 396 $ au 30/04/2024
Postes actifs de Ana Cespedes
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARGENX SE | Directeur/Membre du Conseil | 12/12/2022 | - |
Independent Dir/Board Member | 12/12/2022 | - | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Directeur des opérations | - | - |
London School of Economics & Political Science | Corporate Officer/Principal | - | - |
Congreso de los Diputados | Corporate Officer/Principal | - | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
University of Navarra | Directeur/Membre du Conseil | - | - |
Historique de carrière de Ana Cespedes
Anciens postes connus de Ana Cespedes
Sociétés | Poste | Début | Fin |
---|---|---|---|
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Corporate Officer/Principal | - | - |
Merck KGAA Unsponsored ADR Facility | Sales & Marketing | - | - |
Formation de Ana Cespedes
Universidad Complutense de Madrid | Doctorate Degree |
University of Navarra | Masters Business Admin |
Statistiques
Internationale
Espagne | 5 |
Etats-Unis | 4 |
Pays-Bas | 2 |
Opérationnelle
Corporate Officer/Principal | 7 |
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Government | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ARGENX SE | Health Technology |
Entreprise privées | 5 |
---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Congreso de los Diputados | Government |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Merck KGAA Unsponsored ADR Facility | |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Health Technology |
- Bourse
- Insiders
- Ana Cespedes
- Expérience